levodopa has been researched along with Central Pontine Myelinolysis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Frucht, S; Han, SC; Katus, L | 1 |
| Bhansali, A; Das, L; Dutta, P; Pal, R | 1 |
| Lim, SY; Ng, RX; Tan, AH | 1 |
| Furtado, SV; Hegde, AS; Jagannatha, AT; Joshi, KC; Khanapure, KS; Perikal, PJ | 1 |
| Abdul Halim, S; Mohd Amin, NA | 1 |
| Chen, YC; Ho, PL; Huang, P; Teng, CH; Wu, CC | 1 |
| Hattori, N; Ishiguro, Y; Kawajiri, S; Noda, K; Okuma, Y; Tomizawa, Y; Tosaka, Y | 1 |
| Cha, DR; Kang, YS; Koh, SB; Kwon, DY; Park, KW; Park, MH; Seo, WK | 1 |
| Dietrichs, E; Toft, M | 1 |
| Ahmad, M; Gupta, A; Rizvi, I; Zaidi, N | 1 |
| Chung, YA; Han, SR; Kim, JS; Lee, KS | 1 |
| Prevett, MC; Rossor, MN | 1 |
1 review(s) available for levodopa and Central Pontine Myelinolysis
| Article | Year |
|---|---|
Extrapontine Myelinolysis and Reversible Parkinsonism After Hyponatremia Correction in a Case of Pituitary Adenoma: Hypopituitarism as a Predisposition for Osmotic Demyelination.
Topics: Adenoma; Demyelinating Diseases; Female; Humans; Hydrocortisone; Hyponatremia; Hypopituitarism; Levodopa; Middle Aged; Myelinolysis, Central Pontine; Parkinsonian Disorders; Pituitary Neoplasms; Saline Solution, Hypertonic | 2018 |
11 other study(ies) available for levodopa and Central Pontine Myelinolysis
| Article | Year |
|---|---|
Dramatic Response to Pramipexole in Delayed-Onset Parkinsonism from Osmotic Demyelinating Syndrome.
Topics: Adult; Antiparkinson Agents; Deamino Arginine Vasopressin; Demyelinating Diseases; Dystonia; Epistaxis; Hemostatics; Humans; Hyponatremia; Levodopa; Locked-In Syndrome; Male; Myelinolysis, Central Pontine; Osmotic Pressure; Parkinsonian Disorders; Postoperative Hemorrhage; Pramipexole; Pseudobulbar Palsy; Rhinoplasty; Tetrahydronaphthalenes; Thiophenes; Treatment Failure; Treatment Outcome; von Willebrand Disease, Type 1 | 2020 |
Secondary parkinsonism in a patient of psychogenic polydipsia.
Topics: Adult; Antiparkinson Agents; Contrast Media; Humans; Levodopa; Magnetic Resonance Imaging; Male; Myelinolysis, Central Pontine; Parkinson Disease, Secondary; Polydipsia, Psychogenic; Treatment Outcome | 2017 |
Osmotic Demyelination Syndrome With Evolving Movement Disorders.
Topics: Acute Disease; Adult; Akinetic Mutism; Athetosis; Benserazide; Chorea; Demyelinating Diseases; Dopamine Agents; Drug Combinations; Fluid Therapy; Gastroenteritis; Humans; Hyponatremia; Levodopa; Male; Myelinolysis, Central Pontine; Parkinsonian Disorders; Saline Solution; Time Factors | 2018 |
Treatment response in osmotic demyelination syndrome presenting as severe parkinsonism, ptosis and gaze palsy.
Topics: Blepharoptosis; Diagnosis, Differential; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Myelinolysis, Central Pontine; Parkinsonian Disorders; Syndrome | 2018 |
Acute parkinsonism as an unexpected consequence of pituitary adenoma resection: A case report.
Topics: Adenoma; Adult; Carbidopa; Drug Combinations; Female; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Myelinolysis, Central Pontine; Parkinsonian Disorders; Pituitary Neoplasms | 2019 |
Delayed chorea after recovery from severe akinetic-rigid parkinsonism caused by extrapontine myelinolysis.
Topics: Carbidopa; Chorea; Disease Progression; Dopamine Agonists; Drug Combinations; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Myelinolysis, Central Pontine; Parkinsonian Disorders | 2015 |
Rapidly deteriorating parkinsonism and dysautonomia in patient with central pontine and extrapontine myelinolysis.
Topics: Antiparkinson Agents; Blood Pressure; Fatal Outcome; Gait Disorders, Neurologic; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Myelinolysis, Central Pontine; Parkinson Disease; Primary Dysautonomias; Psychomotor Agitation | 2011 |
Levodopa-responsive parkinsonism in probable extrapontine myelinolysis of the mesencephalon.
Topics: Adult; Antiparkinson Agents; Female; Humans; Levodopa; Mesencephalon; Myelinolysis, Central Pontine; Parkinsonian Disorders; Tomography, Emission-Computed, Single-Photon; Tropanes | 2011 |
Isolated extra pontine myelinolysis presenting as acute onset parkinsonism.
Topics: Acute Disease; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Middle Aged; Myelinolysis, Central Pontine; Parkinson Disease, Secondary; Saline Solution, Hypertonic | 2012 |
Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis.
Topics: Antiparkinson Agents; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Hyponatremia; Isotonic Solutions; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Myelinolysis, Central Pontine; Nerve Tissue Proteins; Parkinsonian Disorders; Protein Binding; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes | 2003 |
Central pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis.
Topics: Acute Disease; Adult; Antiparkinson Agents; Benserazide; Cystic Fibrosis; Drug Combinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Myelinolysis, Central Pontine; Parkinson Disease, Secondary; Pons | 1999 |